GLSI Latest Press Releases

-- March 3, 2026 --

Greenwich LifeSciences Provides Update on Increased Patient Screen Rate in FLAMINGO-01 Globe Newswire 6:00 AM

-- February 24, 2026 --

Greenwich LifeSciences Announces Acceptance of Two Abstracts at AACR Annual Meeting 2026 Globe Newswire 6:00 AM

-- January 27, 2026 --

Greenwich LifeSciences Provides Update on FLAMINGO-01 Cash Burn Rate and Financing Strategy Globe Newswire 6:00 AM

-- January 22, 2026 --

Greenwich LifeSciences Announces FDA Approves Use of Commercially Manufactured GP2 in FLAMINGO-01 Globe Newswire 6:00 AM

-- December 29, 2025 --

Greenwich LifeSciences Extends Lock-up of Directors and Officers to September 30, 2026 Globe Newswire 6:00 AM

-- December 22, 2025 --

Greenwich LifeSciences Provides Additional Updates on FLAMINGO-01 and Corporate Strategy Globe Newswire 6:00 AM

-- December 15, 2025 --

Greenwich LifeSciences Announces Preliminary Analysis Showing 80% Recurrence Rate Reduction in the Open Label Arm of FLAMINGO-01 Globe Newswire 6:00 AM

-- December 8, 2025 --

Greenwich LifeSciences Announces Completion of Enrollment in the Open Label Arm of FLAMINGO-01 Globe Newswire 6:00 AM

-- December 3, 2025 --

Greenwich LifeSciences Provides Global Update on FLAMINGO-01, Screening Over 1,000 Patients to Date Globe Newswire 6:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software